Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer

Figure 1

Reasons for exclusion of patients and the number of eligible patients. The reasons for exclusion and the number of eligible patients are shown in the figure. Abbreviations: FDG, [18 F]-2-fluoro-2-deoxy-D-glucose; PET/CT, positron emission tomography/computed tomography; MBC, metastatic breast cancer.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us